Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Rubin

Showing results (161-170 of 567) with videos related to

Pageof 57
Sort By:
Gastroenterology|August 9, 2005
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazideChristopher D Jahraus, David T Rubin, Ellen J Scherl, et al.
Inflammatory Bowel Diseases|December 4, 2013
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitisRyan Nelson, Chuanhong Liao, Alessandro Fichera, et al.
Inflammatory Bowel Diseases|December 9, 2016
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel DiseaseShivi Siva, David T Rubin, George Gulotta, et al.
Inflammatory Bowel Diseases|October 16, 2023
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative ColitisNoa Krugliak Cleveland, Yusuke Miyatani, Emma A Picker, et al.
ACG Case Reports Journal|July 24, 2015
Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform RashAyal Hirsch, Ruben J Colman, Gabriel D Lang, et al.
Inflammatory Bowel Diseases|October 27, 2020
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor TherapiesDavid T Rubin, Jenny Griffith, Qisu Zhang, et al.
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The challenge of compliance and persistence: focus on ulcerative colitisSunanda V Kane, Diana Brixner, David T Rubin, et al.
Inflammatory Bowel Diseases|July 3, 2009
Quality of care in inflammatory bowel disease: a review and discussionMichael D Kappelman, Lena Palmer, Brendan M Boyle, et al.
Journal of Clinical Gastroenterology|July 25, 2017
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational StudiesDejan Micic, Yuga Komaki, Aleksandar Alavanja, et al.
ACG Case Reports Journal|February 11, 2026
Intestinal Ultrasound-Assisted Endoscopic Management of Acute Bowel Obstruction in a Patient With Crohn's DiseaseYusuke Miyatani, Natalie K Choi, Noa Krugliak Cleveland, et al.
Pageof 57

Showing results (161-170 of 567) with videos related to

Sort By:
Pageof 57
Gastroenterology|August 9, 2005
Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazideChristopher D Jahraus, David T Rubin, Ellen J Scherl, et al.
Inflammatory Bowel Diseases|December 4, 2013
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitisRyan Nelson, Chuanhong Liao, Alessandro Fichera, et al.
Inflammatory Bowel Diseases|December 9, 2016
Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel DiseaseShivi Siva, David T Rubin, George Gulotta, et al.
Inflammatory Bowel Diseases|October 16, 2023
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative ColitisNoa Krugliak Cleveland, Yusuke Miyatani, Emma A Picker, et al.
ACG Case Reports Journal|July 24, 2015
Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform RashAyal Hirsch, Ruben J Colman, Gabriel D Lang, et al.
Inflammatory Bowel Diseases|October 27, 2020
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor TherapiesDavid T Rubin, Jenny Griffith, Qisu Zhang, et al.
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The challenge of compliance and persistence: focus on ulcerative colitisSunanda V Kane, Diana Brixner, David T Rubin, et al.
Inflammatory Bowel Diseases|July 3, 2009
Quality of care in inflammatory bowel disease: a review and discussionMichael D Kappelman, Lena Palmer, Brendan M Boyle, et al.
Journal of Clinical Gastroenterology|July 25, 2017
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational StudiesDejan Micic, Yuga Komaki, Aleksandar Alavanja, et al.
ACG Case Reports Journal|February 11, 2026
Intestinal Ultrasound-Assisted Endoscopic Management of Acute Bowel Obstruction in a Patient With Crohn's DiseaseYusuke Miyatani, Natalie K Choi, Noa Krugliak Cleveland, et al.
Pageof 57